Yan Moore - 27 Oct 2022 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
Chief Medical Officer
Signature
/s/ Barbara Chan as Attorney-in-Fact for Yan Moore
Issuer symbol
OMGAQ
Transactions as of
27 Oct 2022
Net transactions value
$0
Form type
4
Filing time
28 Oct 2022, 18:38:02 UTC
Previous filing
02 Feb 2022
Next filing
02 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Option (Right to Buy) Award $0 +55,000 $0.000000 55,000 27 Oct 2022 Common Stock 55,000 $5.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable as to 25% of the underlying shares on October 27, 2023 and as to 6.25% of the underlying shares upon the Reporting Person's completion of each three full months of continued service to the Issuer thereafter, such that the option will be fully vested and exercisable on October 27, 2026.